A new research paper was published in Volume 17, Issue 8 of Aging-US on August 8, 2025, titled “AI-driven toolset for IPF and aging research associates lung fibrosis with accelerated aging.” ...
Research highlighted the pivotal role of P2RX7 in driving inflammatory and fibrotic processes in idiopathic pulmonary fibrosis (IPF). The research suggests that adenosine triphosphate (ATP), an ...
Cell-cell interactions via proteins and ligand-receptor interactions contribute to PF pathogenesis. Single-cell RNA genome sequencing technique and bio-informatics oriented approaches combined with ...
Interstitial lung disease (ILD) is a collective term for afflictions of the tissues around the air sacs in the lungs, and often presents as a shortness of breath or dry cough. Prolonged inflammation ...
Panelists discuss how idiopathic pulmonary fibrosis (IPF), a progressive and often fatal interstitial lung disease, presents significant clinical challenges due to its variable trajectory, limited ...
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by the excessive accumulation of extracellular matrix components, leading to a gradual decline in lung ...
In a recent study published in PNAS, researchers elucidated immunologic and genetic perturbations in long coronavirus disease (COVID) patients with pulmonary fibrosis. In the present study, ...
Researchers at the University of Calgary studying a lethal lung disease called pulmonary fibrosis have found that neurons ...
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
A research team led by the University of Zurich (UZH) has developed a vaccination-based immunotherapy to target fibroblasts of the cells in the lung and liver in mice. Their findings may lead to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback